Tianjin, China

Xiaohong Qin

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tianjin University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaohong Qin. Retrieved from https://idiyas.com/inventor/xiaohong-qin-tcmwcqih

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Xiaohong Qin in Theranostic Probes

Introduction

Xiaohong Qin is a prominent inventor based in Tianjin, China. He has made significant contributions to the field of biomedical engineering, particularly in the development of theranostic probes. His work focuses on targeting and labeling specific cells, which has important implications for cancer treatment and diagnostics.

Latest Patents

Xiaohong Qin holds 1 patent for his invention titled "A Theranostic Probe and its Use for Targeting and/or Labeling the EGFR Kinase and/or the Cells Expressing EGFR or its Family Members." This innovative probe is designed to enhance the precision of cancer therapies by specifically targeting cells that express the EGFR protein.

Career Highlights

Qin is affiliated with Tianjin University, where he conducts research and develops new technologies in the field of theranostics. His academic background and ongoing research contribute to advancements in medical science, particularly in cancer diagnostics and treatment.

Collaborations

Xiaohong Qin collaborates with notable colleagues, including Lizhi Mi and Xingxing Wang. Their combined expertise fosters a productive research environment that enhances the development of innovative solutions in their field.

Conclusion

Xiaohong Qin's work in theranostic probes exemplifies the intersection of innovation and medical science. His contributions are paving the way for more effective cancer treatments and diagnostics, showcasing the importance of targeted therapies in modern medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…